TL;DR Relapsed leukemia affects 15-20% of acute lymphoblastic leukemia (ALL) patients despite initial treatment success [1] , but multiple advanced treatment options now exist Pi Cancer Care provides comprehensive relapsed leukemia treatment protocols including CAR-T cell therapy, targeted immunotherapy, and stem cell transplantation with 80-85% complete remission rates for eligible patients Treatment selection depends on relapse timing (early vs. late), site of recurrence, a